The Galloway Norton Group is a Clinical Epidemiology and Trials research team focused on immune‑mediated rheumatic diseases. We harness large‑scale real‑world data, advanced biostatistics and pragmatic clinical trials to evaluate treatment safety, optimise therapeutic strategies and reduce health inequalities. Our work spans observational pharmaco‑epidemiology, target‑trial emulation, and early‑phase proof‑of‑concept studies, delivered through wide‑ranging collaborations across the NHS, academia and industry.